Key result
A 10-fold increase in urinary albumin-to-creatinine ratio was associated with a 57% increased risk for the composite cardiovascular endpoint in nondiabetic patients.
Why the study?
Does urinary albumin excretion below the current definition of microalbuminuria predict cardiovascular mortality and events?
Does urinary albumin excretion below the current definition of microalbuminuria predict cardiovascular mortality and events?
Answers are grounded in this paper and cite their sources.
Urinary albumin excretion predicts cardiovascular risk at levels below the current threshold for microalbuminuria, suggesting the definition should be lowered.
Similar results were obtained from a post-hoc analysis of the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study, which included patients with hypertension and left ventricular hypertrophy [23]. Among nondiabetic patients, for every 10-fold increase in UACR, the hazard ratios (HR) for the composite endpoint increased by 57%, for CV mortality by 97.7%, for all cause mortality by 75.2%, for stroke by 51% and for myocardial infarction by 45% (p<0.001 for all comparisons). Ratios were similar in diabetic patients, although for myocardial infarction the trend was weaker and not significant. This study showed a prognostic value for UACR at a level below the current definition of MA, whereas the risk for the composite CV endpoint increased continuously as albuminuria increased. A positive dose-response relationship between increasing UAE and mortality was found in 40,548 inhabitants of Groningen, the Netherlands [10]. After adjustment for other wellrecognized CV risk factors, a higher UAE increased the risk of both CV and non-CV death, with a significantly higher rise for CV mortality than for non-CV mortality (p=0.014). A 2-fold increase in UAE was associated with a RR of 1.29 for CV mortality and 1.12 for non-CV mortality. This relationship was already apparent at levels of albuminuria currently considered as normal.
No takes yet. Share an insight, caveat, or question.
Karagiannis et al. (2008) conducted an editorial in Hypertension and left ventricular hypertrophy (n=40,548). Increased urinary albumin-to-creatinine ratio (UACR) vs. Lower UACR was evaluated on Composite cardiovascular endpoint (HR 1.57, p=<0.001). A 10-fold increase in urinary albumin-to-creatinine ratio was associated with a 57% increased risk for the composite cardiovascular endpoint in nondiabetic patients.
Synapse has enriched 10 related papers. Consider them for comparative context: